A Chinese broker published a note highlighting a rebound in leading medical device companies such as Mindray, APT Medical, and Snibe, recommending them on expectations of valuation recovery and sector-wide opportunities.
The broker is bullish on China's medical device sector, citing policy normalization, innovation, and global expansion as key drivers for a valuation rebound.
Free preview — more China A-share & HK research · About Us · Legal & Privacy